Developmental aspects of fracture healing and the use of pharmacological agents to alter healing

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 4, 2003, Pages 297-303

  Gerstenfeld, Louis C ^a   Einhorn, T A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 D reconstruction; Bone morphogenesis; Fracture; Inflammation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; CELL GROWTH; EMBRYO DEVELOPMENT; FRACTURE HEALING; HUMAN; PERINATAL PERIOD;

EID: 1642513677     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Vortkamp A, Pathi S, Peretti GM, Caruso EM, Zaleske DJ, Tabin CJ. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 1998; 71:65-76.
2. Ferguson C, Alpern E, Miclau T, Helms JA. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 1999; 87:57-66.
3. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003; 88:873-884.
4. Barnes GL, Kostenuick PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999; 14:1805-1815.
5. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves D, Einhorn TA. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001; 169:285-294.
6. Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Tsay A, Barnes GL, Graves DT, Einhorn TA. Impaired fracture healing in the absence of TNF-α. signaling: the role of TNF-α in endochondral cartilage resorption. J Bone Miner Res 2003; 18:1584-1592.
7. Jingushi S, Urabe K, Okazaki K, Hirata G, Sakai A, Ikenoue T, Iwamoto Y. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft. J Orthop Sci 2002; 7:490-494.
8. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994; 127:1755-1766.
9. Le AX, Miclau T, Hu D, Helms JA. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 2001; 19:78-84.
10. Cullinane DM, Fredrick A, Eisenberg SR, Pacicca D, Elman MV, Lee C, Salisbury K, Gerstenfeld LC, Einhorn TA. Induction of a neoarthrosis by precisely controlled motion in an experimental mid-femoral defect. J Orthop Res 2002; 20:579-586.
11. Cullinane DM, Salisbury KT, Alkhiary Y, Eisenberg S, Gerstenfeld L, Einhorn TA. Effects of the local mechanical environment on vertebrate tissue differentiation during repair: does repair recapitulate development? J Exp Biol 2003; 206:2459-2471.
12. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG. An interleukin 1-like factor stimulates bone resorption in vitro. Nature 1993; 306:378.
13. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997; 12:935-941.
14. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001; 16:1004-10014.
15. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-899.
16. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242:1528-1534.
17. Joyce ME, Jinguishi S, Bolander ME. Transforming growth factor-β in the regulation of fracture repair. Orthop Clin North Am 1990; 21:199-220.
18. Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 2001; 83A(Suppl.1):S1-6.
19. Rosier RN, O'Keefe RJ, Hicks DG. The potential role of transforming growth factor-beta in fracture healing. Clin Orthop 1998; 355(Suppl.):S294-S300.
20. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994; 5:651-659.
21. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A, Doty SB, Glaser D, Rosen VM. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995; 13:357-367.
22. Cho T-J, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002; 17:513-520.
23. Einhorn T, Lee C. Bone regeneration: new findings and potential clinical applications. J Am Acad Orthop Surg 2001; 9:157-165.
24. Glowacki J. Angiogenesis in fracture repair. Clin Orthop 1998; 355(Suppl.):S82-89.
25. Rowe NM, Mehrara BJ, Luchs JS, Dudziak ME, Steinbrech DS, Illei PB, Fernandez GJ, Gittes GK, Longaker MT. Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 1999; 42:470-475.
26. Gerber H, Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 2000; 10:223-228.
27. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93:411-422.
28. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5:623-628.
29. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99:9656-9661.
30. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-1180.
31. Pacicca DM, Patel N, Lee C, Salisbury K, Lehmann W, Carvalho R, Gerstenfeld LC, Einhorn TA. Expression of angiogenic factors during distraction osteogenesis. Bone 2003; (in press).
32. Lehmann W, Edgar CM, Cho T-J, Tsay A, Amling M, Rueger JM, Gerstenfeld LC, Einhorn TA. Temporal expression of metalloproteinases and angiogenic factors during murine fracture healing and their dependence on TNF-α. J Bone Miner Res 2002; 17:S227.
33. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143:1545-1553.
34. Yeh LC, Lee JC. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinology 1999; 153:113-124.
35. Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 2001; 81:82-92.
36. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA. Differential inhibition of fracture healing y non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003; 21:670-675.